Literature DB >> 29845631

Species differences in bile acids II. Bile acid metabolism.

Rhishikesh Thakare1, Jawaher Abdullah Alamoudi1, Nagsen Gautam1, A David Rodrigues2, Yazen Alnouti1.   

Abstract

One of the mechanisms of drug-induced liver injury (DILI) involves alterations in bile acid (BA) homeostasis and elimination, which encompass several metabolic pathways including hydroxylation, amidation, sulfation, glucuronidation and glutathione conjugation. Species differences in BA metabolism may play a major role in the failure of currently used in vitro and in vivo models to predict reliably the DILI during the early stages of drug discovery and development. We developed an in vitro cofactor-fortified liver S9 fraction model to compare the metabolic profiles of the four major BAs (cholic acid, chenodeoxycholic acid, lithocholic acid and ursodeoxycholic acid) between humans and several animal species. High- and low-resolution liquid chromatography-tandem mass spectrometry and nuclear magnetic resonance imaging were used for the qualitative and quantitative analysis of BAs and their metabolites. Major species differences were found in the metabolism of BAs. Sulfation into 3-O-sulfates was a major pathway in human and chimpanzee (4.8%-52%) and it was a minor pathway in all other species (0.02%-14%). Amidation was primarily with glycine (62%-95%) in minipig and rabbit and it was primarily with taurine (43%-81%) in human, chimpanzee, dog, hamster, rat and mice. Hydroxylation was highest (13%-80%) in rat and mice followed by hamster, while it was lowest (1.6%-22%) in human, chimpanzee and minipig. C6-β hydroxylation was predominant (65%-95%) in rat and mice, while it was at C6-α position in minipig (36%-97%). Glucuronidation was highest in dog (10%-56%), while it was a minor pathway in all other species (<12%). The relative contribution of the various pathways involved in BA metabolism in vitro were in agreement with the observed plasma and urinary BA profiles in vivo and were able to predict and quantify the species differences in BA metabolism. In general, overall, BA metabolism in chimpanzee is most similar to human, while BA metabolism in rats and mice is most dissimilar from human.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  LC-MS/MS; bile acids; drug-induced liver injury; human; liver S9 fractions; preclinical species

Mesh:

Substances:

Year:  2018        PMID: 29845631     DOI: 10.1002/jat.3645

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  7 in total

1.  Quantification of common and planar bile acids in tissues and cultured cells.

Authors:  Stephanie J Shiffka; Jace W Jones; Linhao Li; Ann M Farese; Thomas J MacVittie; Hongbing Wang; Peter W Swaan; Maureen A Kane
Journal:  J Lipid Res       Date:  2020-07-22       Impact factor: 5.922

Review 2.  Inflammation and Cell Death During Cholestasis: The Evolving Role of Bile Acids.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Gene Expr       Date:  2019-06-28

3.  Method development and validation of ursodiol and its major metabolites in human plasma by HPLC-tandem mass spectrometry.

Authors:  Márcio Cardoso Pinto; Danilo Chorfi Berton; Alexandre Cavenatti de Oliveira; Carolina Martins Lazaro; Silvana Aparecida Calafatti Carandina
Journal:  Clin Pharmacol       Date:  2019-01-04

4.  Urinary BA Indices as Prognostic Biomarkers for Complications Associated with Liver Diseases.

Authors:  Wenkuan Li; Jawaher Abdullah Alamoudi; Nagsen Gautam; Devendra Kumar; Macro Olivera; Yeongjin Gwon; Sandeep Mukgerjee; Yazen Alnouti
Journal:  Int J Hepatol       Date:  2022-03-30

5.  Quantitative Profiling of Bile Acids in Feces of Humans and Rodents by Ultra-High-Performance Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry.

Authors:  Xiaoxu Zhang; Xiaoxue Liu; Jiufang Yang; Fazheng Ren; Yixuan Li
Journal:  Metabolites       Date:  2022-07-11

6.  Bile Duct Ligation Impairs Function and Expression of Mrp1 at Rat Blood-Retinal Barrier via Bilirubin-Induced P38 MAPK Pathway Activations.

Authors:  Ping Li; Yiting Yang; Zijin Lin; Shijin Hong; Ling Jiang; Han Zhou; Lu Yang; Liang Zhu; Xiaodong Liu; Li Liu
Journal:  Int J Mol Sci       Date:  2022-07-11       Impact factor: 6.208

7.  Analytical performance and method comparison of a quantitative point-of-care immunoassay for measurement of bile acids in cats and dogs.

Authors:  Kristina Weiler; Katharina Kleber; Sabine Zielinsky; Andreas Moritz; Natali Bauer
Journal:  J Vet Diagn Invest       Date:  2020-10-28       Impact factor: 1.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.